Expansion Opportunity AMT has a revenue range of 50M-100M and operates in wound care, ostomy, urological and tracheostomy supplies for long-term care, home health, hospice, and assisted living. This positions them for cross-sell of related medical supplies and expanded contracts with large multi-site providers or post-acute networks seeking integrated wound and durable medical equipment solutions.

Acquisition Footprint AMT was acquired by One Equity Partners and The Silverfern Group in 2020. This suggests a potential openness to strategic partnerships or investment-backed collaborations, including joint ventures, distributor alliances, or capacity expansion initiatives with manufacturers and logistics partners.

Wound Care Focus AMT specializes in Medicare Part B billing for wound care and related supplies, serving long-term care facilities. This creates opportunities to offer revenue cycle optimization services, payer-approval improvements, and electronic billing integrations for facilities aiming to streamline reimbursement.

UriCap Collaboration History of launching UriCap with TillaCare indicates a track record in external urinary collection systems and female UI management. Sales conversations can explore portfolio expansion in urinary health products and potential co-development or exclusive distribution deals for accessory devices in long-term care settings.

Data & Compliance Needs Past data breach investigation and PHI safeguarding concerns highlight a potential demand for enhanced data security, HIPAA-compliant solutions, and privacy-focused vendor partnerships. This can translate into offering compliant IT services, secure billing integrations, and risk management partnerships to protect patient data.